BRCA1 and cancer: For example, a meta-analysis based only on tests for BRCA1/2 variants identified anxiety and cancer-specific distress among the carrier participants [24]; soon after receiving test results, carriers’ emotional distress increased slightly and returned to the pretesting levels with additional time, whereas the noncarriers experienced decreases in both general and cancer-specific distress soon after testing.